Cepheid (NASDAQ:CPHD)
CAPS Rating:
A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.
RSS Headlines
Fool UK
Recs
this is speculation I must admit, but do not bet against the IRISH